Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1543 results found
2025 ∙ Cheuyem, F. Z. L. Amani, A. Achangwa, C. Ajong, B. N. Minkandi, C. A. Zeh, M. M. M. K. Ntsek, L. L. E. Essomba, J. P. Jiogue, R. C. Ndagijimana, O. Nchanji, N. E. Danwang, C.
COVID- 19 vaccine uptake and its determinants in Cameroon: a systematic review and meta-analysis (2021-2024)
Africa Cameroon All age groups Healthcare workers COVID-19 Coverage Acceptance
Rating:
Not applicable
2025 ∙ Karimi, R. Norozirad, M. Esmaeili, F. Mansourian, M. Marateb, H. R.
COVID-19 Vaccination and Cardiovascular Events: A Systematic Review and Bayesian Multivariate Meta-Analysis of Preventive Benefits and Risks
All age groups COVID-19 Safety Administration
Rating:
Critically low
2025 ∙ McCosker, L. K. Dyer, B. Sudarmana, T. Seale, H. Ware, R. S.
COVID-19 vaccination uptake in people experiencing homelessness during the first three years of the global COVID-19 vaccination effort: A systematic review and meta-analysis
All age groups COVID-19 Coverage Administration
Rating:
Not applicable
2025 ∙ Cheuyem, F. Z. L. Amani, A. Nkodo, I. C. A. Boukeng, L. B. K. Edzamba, M. F. Nouko, A. Guissana, E. O. Ngos, C. S. Achangwa, C. Mouangue, C.
COVID-19 vaccine acceptance and hesitancy in Cameroon: a systematic review and meta-analysis
Africa Cameroon All age groups Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Pimenta, P. D. C. de Aquino Lima, T. C. Geraldine, V. G. S. Tourinho, F. S. do Nascimento, M. C. Novaes, R. D. Dias, L. M. R. P.
COVID-19 Vaccine Adverse Events by Country Income Level: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
All age groups COVID-19 Safety
Rating:
Low
2025 ∙ Mohammadi, S. Sisay, M. M. Saraswati, P. W. Osman, A. K. Zuithoff, N. P. A. Weibel, D. Sturkenboom, M. Ahmadizar, F.
COVID-19 vaccine safety studies among special populations: A systematic review and meta-analysis of 120 observational studies and randomized clinical trials
All age groups COVID-19 Safety
Rating:
Critically low
2025 ∙ Al hashimi, F. Shuaib, S. E. Bragazzi, N. L. Chen, S. Wu, J.
COVID-19 Vaccine Timing and Co-Administration with Influenza Vaccines in Canada: A Systematic Review with Comparative Insights from G7 Countries
Americas Canada All age groups Healthcare workers COVID-19 Influenza Efficacy/effectiveness Administration
Rating:
Critically low
2025 ∙ Blukacz, A. Obach, A. Vasquez, P. Campana, C. Huerta, C. Bernal, Y. Cabieses, B.
Determinants of COVID-19 and non-COVID-19 vaccine confidence in low- and middle-income countries: A systematic review of qualitative evidence and thematic synthesis
All age groups Low and Middle Income Countries COVID-19 Acceptance
Rating:
Not applicable
2025 ∙ Bachmann, M. Gultekin, N. Stanga, Z. Fehr, J. S. Ulgur, I. I. Schlagenhauf, P.
Disparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Moore, M. Anderson, L. Schiffer, J. T. Matrajt, L. Dimitrov, D.
Durability of COVID-19 vaccine and infection induced immunity: A systematic review and meta-regression analysis
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
Loading...